Heartfelt Technologies celebrates FOOT Study publication
The study shows the Heartfelt Device detects heart failure changes up to 13 days in advance. It thanks NHS collaborators.
See the latest news and media coverage for Heartfelt Technologies. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-powered non-contact telemonitoring for heart failure patients
hftech.orgLast updated
In short: Heartfelt Technologies expanded its clinical footprint in the US and UK while proving its AI device's ability to predict heart failure events early.
The study shows the Heartfelt Device detects heart failure changes up to 13 days in advance. It thanks NHS collaborators.
The installation supports the FDA-approved HEARTFELT Study for 1,600 patients, with remote monitoring by Connect America at The Heart Center CT.
The pilot demonstrates reliable AI-enabled monitoring for heart failure patients in community settings, reducing readmission risks without added burden. The team seeks US research partners at HFSA ASM2025.
An Innovate UK-funded trial is underway. An NIHR-backed study begins recruiting this summer in the UK. An FDA IDE-B approved trial starts in the US in late summer/early autumn 2025.
Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information...
Novel technology outperforms clinical standard for life-threatening condition...
The advent of remote monitoring ... of these technologies is their reliance on consistent patient adherence to measurements and/or data transmission, which may impact their...
Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials Receive the the...
Track Heartfelt Technologies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.